Release Date: 18/10/13 18:03 Summary: Appendix 3Y - Correction Price Sensitive: No Download Document 315.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%